Guorui Yao

Guorui Yao

Auto-generated profile, based on publicly available information

Guorui Yao

Department of Physiology and Biophysics, University of California, Irvine, CA 92697, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2017 in Nature
Verified
Journal Article
Closed access
PDF file
ACAaron Chevalier
Aaron Chevalier
DSDaniel-Adriano Silva
Daniel-Adriano Silva
GRGabriel J. Rocklin
Gabriel J. Rocklin
DHDerrick R. Hicks
Derrick R. Hicks
RVRenan Vergara
Renan Vergara
DBDavid Baker
David Baker

1 February 2012 in Genes & Development
Verified
Journal Article
Closed access
PDF file
YZYinong Zong
Yinong Zong
BZBin Zhang
Bin Zhang
SGShenyan Gu
Shenyan Gu
KLKwangkook Lee
Kwangkook Lee
JZJie Zhou
Jie Zhou
RJRongsheng Jin
Rongsheng Jin
Synapses are the fundamental units of neural circuits that enable complex behaviors. The neuromuscular junction (NMJ), a synapse formed between a motoneuron and a muscle fiber, has contributed greatly to understanding of the general principles of synaptogenesis as well as of neuromuscular disorders. NMJ formation requires neural agrin, a motoneuron-derived protein, which interacts with LRP4 (low-density lipoprotein receptor-related protein 4) to activate the receptor tyrosine kinase MuSK (muscle-specific kinase). However, little is known of how signals are transduced from agrin to MuSK. Here, we present the first crystal structure of an agrin–LRP4 complex, consisting of two agrin–LRP4 heterodimers. Formation of the initial binary complex requires the z8 loop that is specifically present in neuronal, but not muscle, agrin and that promotes the synergistic formation of the tetramer through two additional interfaces. We show that the tetrameric complex is essential for neuronal agrin-induced acetylcholine receptor (AChR) clustering. Collectively, these results provide new insight into the agrin–LRP4–MuSK signaling cascade and NMJ formation and represent a novel mechanism for activation of receptor tyrosine kinases.

10 October 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
KLKwangkook Lee
Kwangkook Lee
SGShenyan Gu
Shenyan Gu
LJLei Jin
Lei Jin
TLThi Tuc Nghi Le
Thi Tuc Nghi Le
LCLuisa W. Cheng
Luisa W. Cheng
RJRongsheng Jin
Rongsheng Jin
Botulinum neurotoxins (BoNTs) are produced by Clostridium botulinum and cause the fatal disease botulism, a flaccid paralysis of the muscle. BoNTs are released together with several auxiliary proteins as progenitor toxin complexes (PTCs) to become highly potent oral poisons. Here, we report the structure of a ∼760 kDa 14-subunit large PTC of serotype A (L-PTC/A) and reveal insight into its absorption mechanism. Using a combination of X-ray crystallography, electron microscopy, and functional studies, we found that L-PTC/A consists of two structurally and functionally independent sub-complexes. A hetero-dimeric 290 kDa complex protects BoNT, while a hetero-dodecameric 470 kDa complex facilitates its absorption in the harsh environment of the gastrointestinal tract. BoNT absorption is mediated by nine glycan-binding sites on the dodecameric sub-complex that forms multivalent interactions with carbohydrate receptors on intestinal epithelial cells. We identified monosaccharides that blocked oral BoNT intoxication in mice, which suggests a new strategy for the development of preventive countermeasures for BoNTs based on carbohydrate receptor mimicry. Food-borne botulinum neurotoxin (BoNT) poisoning results in fatal muscle paralysis. But how can BoNT–a large protein released by the bacteria clostridia–survive the hostile gastrointestinal (GI) tract to gain access to neurons that control muscle contraction? Here, we report the complete structure of a bimodular ∼760 kDa BoNT/A large progenitor toxin complex (L-PTC), which is composed of BoNT and four non-toxic bacterial proteins. The architecture of this bacterial machinery mimics an Apollo lunar module, whereby the “ascent stage” (a ∼290 kDa module) protects BoNT from destruction in the GI tract and the 3-arm “descent stage” (a ∼470 kDa module) mediates absorption of BoNT by binding to host carbohydrate receptors in the small intestine. This new finding has helped us identify the carbohydrate-binding sites and the monosaccharide IPTG as a prototypical oral inhibitor, which extends survival following lethal BoNT/A intoxication of mice. Hence, pre-treatment with small molecule inhibitors based on carbohydrate receptor mimicry can provide temporary protection against BoNT entry into the circulation.

13 June 2016 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
GYGuorui Yao
Guorui Yao
SZSicai Zhang
Sicai Zhang
SMStefan Mahrhold
Stefan Mahrhold
KLKwok Ho Lam
Kwok Ho Lam
DSDaniel Stern
Daniel Stern
RJRongsheng Jin
Rongsheng Jin
BoNT/A1 invades motoneurons by binding to the neuronal receptor SV2. A combination of structural, biophysical and cellular analyses reveal that BoNT/A1 binding and uptake require glycosylation of SV2. Botulinum neurotoxin serotype A1 (BoNT/A1), a licensed drug widely used for medical and cosmetic applications, exerts its action by invading motoneurons. Here we report a 2.0-Å-resolution crystal structure of the BoNT/A1 receptor-binding domain in complex with its neuronal receptor, glycosylated human SV2C. We found that the neuronal tropism of BoNT/A1 requires recognition of both the peptide moiety and an N-linked glycan on SV2. This N-glycan—which is conserved in all SV2 isoforms across vertebrates—is essential for BoNT/A1 binding to neurons and for its potent neurotoxicity. The glycan-binding interface on SV2 is targeted by a human BoNT/A1-neutralizing antibody currently licensed as an antibotulism drug. Our studies reveal a new paradigm of host-pathogen interactions, in which pathogens exploit conserved host post-translational modifications, thereby achieving highly specific receptor binding while also tolerating genetic changes across multiple isoforms of receptors.

1 August 2013 in Neuroscience Letters
Verified
Journal Article
Closed access
XLXinxin Li
Xinxin Li
YLYiqian Liu
Yiqian Liu
QZQiuyang Zheng
Qiuyang Zheng
GYGuorui Yao
Guorui Yao
PCPeng Cheng
Peng Cheng
Yunwu ZhangYunwu Zhang
Yunwu Zhang

1 March 2015 in Progress in Biophysics and Molecular Biology
Verified
Journal Article
Open access
KLKwok Ho Lam
Kwok Ho Lam
GYGuorui Yao
Guorui Yao
RJRongsheng Jin
Rongsheng Jin
Botulinum neurotoxins (BoNTs) are among the most deadly toxins known. They act rapidly in a highly specific manner to block neurotransmitter release by cleaving the soluble N-ethylmaleimide sensitive factor attachment protein receptor (SNARE) complex at neuromuscular junctions. The extreme toxicity of BoNTs relies predominantly on their neurotropism that is accomplished by recognition of two host receptors, a polysialo-ganglioside and in the majority of cases a synaptic vesicle protein, through their receptor-binding domains. Two proteins, synaptotagmin and synaptic vesicle glycoprotein 2, have been identified as the receptors for various serotypes of BoNTs. Here, we review recent breakthroughs in the structural studies of BoNT-protein receptor recognitions that highlight a range of diverse mechanisms by which BoNTs manipulate host neuronal proteins for highly specific uptake at neuromuscular junctions.